Cory Ross Weissman
Associate Professor of Clinical Psychiatry and Medical Director of Interventional Psychiatry at UC San Diego Health
Data updated
Research Footprint
Cory Ross Weissman appears in 6 tracked papers (2019–2022), most studied alongside LSD, Psilocybin and Ayahuasca, across Anxiety Disorders, Depressive Disorders and Suicidality.
Most-cited paper: Microdosing psychedelics: personality, mental health, and creativity differences in microdosers (169 citations).
Frequent co-authors: Richard Zeifman, Rotem Petranker and Sandeep Nayak.
Background & Research
Cory Weissman, MD, PhD, is a psychiatrist at the University of California, San Diego, where he serves as Associate Professor of Clinical Psychiatry and Medical Director of Interventional Psychiatry. His work centers on treatment-resistant mood disorders and suicide prevention, with research spanning psychedelic-assisted therapy, microdosing, ketamine/esketamine, and transcranial magnetic stimulation. He appears as a coauthor on multiple psychedelic and suicidality papers in the clinical literature.
Key Impact
He is a UC San Diego psychiatrist whose research and clinical work focus on interventional treatments for suicidality, including psychedelic therapies and other novel brain-based interventions.
Collaboration Network
6 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Cory Ross Weissman is associated with.